Main menu

Pages

Fighting Alzeimer's Disease: Hong Kong's Science and Technology Park

featured image

Hong Kong’s startup scene, combined with the industrial strength of the Greater Bay Area, combines innovation and entrepreneurship with universities and research institutes.

In Hong Kong’s science and technology park, a research cluster called InnoHK is developing a global collaboration. Health @ InnoHK focuses on healthcare and AIR @ InnoHK focuses on his AI and robotics technology. Science Park is currently working with the University College of London and Stanford University.

Nancy Ip, Director of the Hong Kong Center for Neurodegenerative Diseases, explains the impact of this collaboration.

“The Hong Kong Science Park has provided much-needed infrastructure for innovation in technology development. can be achieved.

One of the projects we are working on together is the development of a blood-based biomarker test for Alzheimer’s disease. So this is a very exciting project for us because it really shows the power of cooperation between the three institutions. As the global population ages, the prevalence of neurodegenerative diseases is increasing significantly as they are age-related diseases. ”

AIR@InnoHK collaborates with people like Helen Meng of the Center for Perceptual and Interactive Intelligence, part of the Chinese University of Hong Kong. As Helen Meng explains, they are working with her MIT and others to develop wearable electronics.

“They can use it for rehabilitation.It can also be used in sports.It can be used in sports training for athletes where you can use sensors embedded in clothing to measure the movement of athletes during training.”

One company that is part of that ecosystem is Invivogen, a French company that manufactures cutting-edge bioresearch tools.

Hong Kong Chief Business Officer Xiaobing Li explains the following example: reporter cell line.

“The cells are actually in the device and used for vaccine development. After vaccination, the authors use a reporter cell line to test the post-vaccination immune response. To do this, flow You have to use a cytometer, the equipment can be as expensive as €500,000, but here at Science Park we offer a flow cytometer.

The Hong Kong Science and Technology Parks Corporation (HKSTP for short) is now celebrating its 20th anniversary and has over 1000 companies. Albert Wong is his CEO and explains the organization’s future plans.

“We need to grow exponentially by leveraging our fundamental strengths, such as basic research and access to markets. And I’ve spent years in very large companies, and the common denominator is, first of all, you have limited resources, and you have to make the most of them.

So how does HKSTP overcome these challenges? Albert Wong again.

“Electronic labs, biomedical labs, data, robotics, even AI go into virtual labs so people can participate. You can start at

As Albert Wong explains, the Greater Bay Area around Hong Kong could offer a huge product market.

“80 million population within an hour or two travel zone. This is a huge market opportunity. Hong Kong can also play a role in bringing technology from China, Hong Kong, to the Southeast Asian region.”

.

Comments